MOUD Pre-Treatment + Telehealth for Opioid Use Disorder

(W-JCOIN Trial)

Recruiting at8 trial locations

Overseen by Michele Staton, MSW, PhD

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Michele Staton

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial will test the effectiveness of delivering medication for opioid use disorder (MOUD) pre-treatment via telehealth, alone and with peer navigation, to increase MOUD initiation and maintenance in the community following jail release. This trial will focus on incarcerated women in 6 experimental and 3 control sites in Kentucky. Enrollment is not open to the general public.

Research Team

Michele Staton, MSW, PhD

Principal Investigator

University of Kentucky

Eligibility Criteria

This trial is for incarcerated women in Kentucky who have been jailed for at least a week, show significant opioid use with an ASSIST score of 4 or more, and are willing to start treatment for opioid addiction. It's not open to the public and excludes those with cognitive impairments.

Inclusion Criteria

Incarceration period of at least 7 days

You must agree to participate in medication treatment before starting the study.

You have used opioid drugs (prescription or street) frequently and have a high score on a screening test called ASSIST.

Exclusion Criteria

I have difficulty with memory or thinking clearly.

Treatment Details

Interventions

• MOUD Pre-Treatment Telehealth (Other)
• MOUD Pre-Treatment Telehealth and Peer Navigator (Other)
• Services as Usual (Other)

Trial Overview The study tests if telehealth services before release from jail can help women start and stick with medication treatments for opioid addiction. Some will also get support from peers who've had similar experiences, while others receive usual care without these additions.

Participant Groups

Group I: MOUD Pre-Treatment Telehealth and Peer Navigator Experimental Treatment 1 Intervention

Telehealth connection to a community MOUD provider, in addition to a peer navigator

Group II: MOUD Pre-Treatment Telehealth Experimental Treatment 1 Intervention

Telehealth connection to a community MOUD provider.

Group III: Services as Usual (SAU) Active Control 1 Intervention

Substance abuse program (SAP) managed by the Kentucky Department of Corrections, with the option to initiate MOUD prior to jail release.

Who Is Running the Clinical Trial?

Michele Staton

Lead Sponsor

Trials

5

Recruited

1,600+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials

2,658

Recruited

3,409,000+

Dr. Nora Volkow

National Institute on Drug Abuse (NIDA)

Chief Executive Officer since 2003

MD from National Autonomous University of Mexico

Dr. Nora Volkow

National Institute on Drug Abuse (NIDA)

Chief Medical Officer since 2003

MD from National Autonomous University of Mexico